Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQuadrise Regulatory News (QED)

Share Price Information for Quadrise (QED)

Share Price is delayed by 15 minutes
Get Live Data
1.89    -0.25 (-11.68%)
Bid:
1.895
Ask:
2.19
Spread: 0.295 (15.567%)
Market Cap: £37.92m
QED Live PriceLast checked at - London Stock Exchange

Intraday Quadrise Share Chart

Valkor Update

24 Aug 2023 12:29

RNS Number : 3724K
Quadrise PLC
24 August 2023
 

24 August 2023

Quadrise Plc ("Quadrise" or the "Company")

Valkor Update

Quadrise Plc (AIM:QED), the supplier of innovative energy solutions for a cleaner planet, provides an update on its project with Valkor Technologies LLC ('Valkor') in Utah, USA.

A meeting of the State of Utah's Board of Oil, Gas and Mining ('the Board') was held yesterday to review a unitisation plan involving drilling of up to 119 wells to establish the Asphalt Ridge Enhanced Recovery Unit for the in-situ production of heavy oil from sands by Valkor, on behalf of project sponsors Heavy Sweet Oil LLC and AC Oil LLC.

The Board denied the order on the basis that without a producing well in place, there was not yet sufficient evidence of an oil deposit to support the unitisation plan at this time. The decision does not prevent Valkor from drilling the 4 pilot wells already granted by the Board in December 2022. Pilot well drilling will be necessary to support a further application for unitisation in due course.

Quadrise is now working with Valkor to assess and clarify any impact on the conditional site license and supply agreement for Quadrise's emulsion fuel technology announced on 12 June 2023 and a further announcement will be made as soon as practicable.

For additional information, please contact:

 

Quadrise Plc

+44 (0)20 7031 7321

Andy Morrison, Chairman

Jason Miles, Chief Executive Officer

Nominated Adviser

Cenkos Securities plc

+44 (0)20 7397 8900

Ben Jeynes

Katy Birkin

Joint Brokers

Shore Capital Stockbrokers Limited

 

 

+44 (0)20 7408 4090

Toby Gibbs, Rachel Goldstein (Corporate Advisory)

Fiona Conroy (Corporate Broking)

 

 

 

VSA Capital Limited

Andrew Raca (Corporate Finance)

Andrew Monk (Corporate broking)

+44 (0)20 3005 5000

Public & Investor Relations

 

 

Vigo Consulting

Patrick D'Ancona

Finlay Thomson

+44 (0)20 7390 0230

 

About Quadrise

Quadrise is the supplier of MSAR® and bioMSAR™ emulsion technology, fuels and biofuels, providing innovative solutions to reduce energy costs and greenhouse gas emissions today for clients in the global power generation, shipping, industrial and refining industries.

Learn more at: www.quadrise.com

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR") and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDFZLFLXVLLBBQ
Date   Source Headline
24th May 20127:00 amRNSFinal Results - Part 2
24th May 20127:00 amRNSFinal Results - Part 1
23rd May 20127:00 amRNSiQ Fund agrees further £70m financing with M&G
15th May 20123:23 pmRNSDirector/PDMR Shareholding
14th May 201210:52 amRNSNotice of Preliminary Results
4th May 20124:02 pmRNSDirector/PDMR Shareholding
30th Apr 201210:35 amRNSBlocklisting Interim Review
3rd Apr 20127:00 amRNSiQ Fund Agrees £158 million refinancing
2nd Apr 201210:32 amRNSTotal Voting Rights
29th Mar 20127:00 amRNSSale of Emersons Green
23rd Mar 201210:58 amRNSDirector/PDMR Shareholding
29th Feb 20124:54 pmRNSTotal Voting Rights
28th Feb 20127:00 amRNSAcquisition
20th Feb 20121:32 pmRNSHolding(s) in Company
16th Feb 20122:44 pmRNSDirectorate Change
2nd Feb 20127:00 amRNSInterim Management Statement
1st Feb 20122:30 pmRNSNotice of IMS
31st Jan 20125:44 pmRNSTotal Voting Rights
17th Jan 201211:04 amRNSDirector/PDMR Shareholding
29th Dec 201110:22 amRNSTotal Voting Rights
13th Dec 20113:33 pmRNSDirector/PDMR Shareholding
29th Nov 20117:00 amRNSHalf Yearly Report
22nd Nov 20112:55 pmRNSHolding(s) in Company
17th Nov 20117:00 amRNSDisposal
14th Nov 20112:20 pmRNSDirector/PDMR Shareholding
4th Nov 20114:04 pmRNSHolding(s) in Company
1st Nov 201110:27 amRNSBlocklisting Interim Review
20th Oct 20112:43 pmRNSNotice of Results
18th Oct 201110:03 amRNSAdditional Listing
13th Oct 20112:34 pmRNSDirector/PDMR Shareholding
13th Oct 20117:00 amRNSDisposal
11th Oct 201110:03 amRNSHolding(s) in Company
10th Oct 20111:10 pmRNSHolding(s) in Company
22nd Sep 20112:30 pmRNSDirector/PDMR Shareholding
21st Sep 20118:30 amRNSHolding(s) in Company
19th Sep 20111:53 pmRNSHolding(s) in Company
16th Sep 20114:57 pmRNSDirector/PDMR Shareholding
6th Sep 20114:31 pmRNSAnnual Information Update
5th Sep 20114:01 pmRNSResult of AGM
31st Aug 20115:20 pmRNSHolding(s) in Company
16th Aug 20111:09 pmRNSDirector/PDMR Shareholding
11th Aug 201110:26 amRNSNotice of AGM
10th Aug 20117:00 amRNSInterim Management Statement
1st Aug 20113:14 pmRNSNotice of IMS
14th Jul 201112:08 pmRNSAnnual Financial Report
13th Jul 20113:10 pmRNSDirector/PDMR Shareholding
6th Jul 20117:00 amRNSDirectorate Change
14th Jun 201111:18 amRNSDirector/PDMR Shareholding
10th Jun 20117:00 amRNSDisposal
9th Jun 20114:41 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.